Stalevo May Be More Effective Than Other Medications for Early Parkinson’s, Meta-analysis Shows
Stalevo (levodopa, carbidopa, and entacapone combination therapy) may be more effective but seems to be associated with…
Articles by Catarina Silva, MSc
Fatigued Patients Walk Slower, Endure Shorter Distances, Study Finds
Fatigue may compromise and predict Parkinson’s patients’ mobility and their ability to walk over long distances, according to…
Discovery May Lead to Better Treatments for Tremor, Other Movement Disorders
Two distinct proteins previously known to play key roles in the development of tremor associated with neurodegenerative diseases now have…
NLX-112 Eases L-dopa Dyskinesia in Marmosets With Parkinson’s, Study Says
An investigational therapy known as NLX-112 (befiradol) may hold promise to treat levodopa-induced dyskinesia, a complication of…
Levels of Progranulin Protein May Affect Parkinson’s Severity, Progression
Blood levels of progranulin — a protein whose deficiency has been linked to neurodegeneration — may reflect Parkinson’s severity…
Selenium Mineral Levels Increased in Cerebrospinal Fluid of Parkinson’s Patients, Research Suggests
People with Parkinson’s disease may have higher levels of selenium — a mineral with antioxidant properties —…
Iron Levels in Brain May Predict Parkinson’s Severity and Cognitive Decline, Study Finds
Likely cognitive decline, dementia risk, and the severity of motor symptoms in Parkinson’s disease might be tracked by measuring…
New Cellular Model Can Reconstruct Entire Process of Lewy Body Formation in Parkinson’s Disease, Study Says
Scientists have developed a new cellular model that can help reconstruct the entire process of Lewy body formation —…
Scientists Uncover New Therapeutic Molecule BT13 That May Possibly Protect Against Neurodegeneration
Scientists have uncovered a new therapeutic molecule, called BT13, that can get to the brain to boost dopamine levels…
Memory-related Mild Cognitive Impairment May Be Linked to More Severe Alpha-Synuclein Buildup, Researchers Say
Memory-related mild cognitive impairment in Parkinson’s disease may be associated with a more severe buildup of alpha-synuclein protein…